Prescription Drugs

Is it okay to use type 2 diabetes medications in people with type 1 diabetes?
Recently, I was approached by a colleague who had seen a patient with type 1 diabetes using a glucagon-like peptide-1 receptor agonist in combination with basal bolus insulin to manage their glucose levels.
Rexall teams up with Novo Nordisk Canada to deliver T2D, obesity medications to patients’ homes
The new initiative, Novo Nordisk Care Rx will leverage Rexall’s online pharmacy, Rexall Direct to deliver select medications including semaglutide injections.

What I wish prescribers knew about compounding

A pharmacist's honest, friendly note to the clinicians we work with every day.
When medication use makes it harder for travellers to ‘beat the heat’

Counselling on risk reduction strategies and early recognition of heat-related illness is important.
Second new drug for early Alzheimer’s disease is approved by Health Canada

Kisunla (donanemab) is a new IV anti-amyloid beta-directed monoclonal antibody for adults with mild cognitive impairment or mild dementia due to Alzheimer's disease.
B.C. ‘moving as quickly as possible’ to implement expanded scope: Ministry of Health

But don’t expect to be paid for ordering labs—because no one gets paid for that, noted a ministry official at the BCPhA conference.
Health Canada approves 2nd generic version of Ozempic—and it's Canadian

Canada is the first of the G-7 countries to authorize generic semaglutide.
Ozempic (semaglutide) going generic is keeping me up at night. For two very specific reasons.

This volatility in pricing is going to impact supply. And with cheaper versions on the market, demand is going to skyrocket.
St. John’s wort revisited: What clinicians should know now

Research suggests benefits in mild-to-moderate depression, but medication interactions limit its role for many patients. Lower-dose formulations may reduce risk.
Do certain pharmacotherapies for IBS increase the risk of mortality?

Study examines the risk of all-cause mortality with approved and off-label pharmacotherapies for irritable bowel syndrome (IBS).
Health Canada approves first generic version of Ozempic in the country

The federal agency says it continues to review eight other generic semaglutide submissions from other companies.
Newfoundland and Labrador health minister pushes Ottawa to negotiate pharmacare deal

The Pharmacare Act requires Ottawa to negotiate the terms of funding agreements with provinces and territories.

Is it okay to use type 2 diabetes medications in people with type 1 diabetes?

Rexall teams up with Novo Nordisk Canada to deliver T2D, obesity medications to patients’ homes

What I wish prescribers knew about compounding

When medication use makes it harder for travellers to ‘beat the heat’

Second new drug for early Alzheimer’s disease is approved by Health Canada

B.C. ‘moving as quickly as possible’ to implement expanded scope: Ministry of Health

Health Canada approves 2nd generic version of Ozempic—and it's Canadian

Ozempic (semaglutide) going generic is keeping me up at night. For two very specific reasons.

St. John’s wort revisited: What clinicians should know now

Do certain pharmacotherapies for IBS increase the risk of mortality?

Health Canada approves first generic version of Ozempic in the country

Newfoundland and Labrador health minister pushes Ottawa to negotiate pharmacare deal